Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Feelings. I have them. Tomorrow.
I called a good feeling yesterday
I have a BIG feeling about somthing
I definitely have feelings
I have a great feeling
A really good feeling
I have a good feeling
HOW CAN YOU PUT A PRICE ON THIS TECHNOLOGY? Well YOU CAN and its HUGE >$10 a share HUGE. PMCB will change the way cancers and diabetes are treated and it will save millions maybe billions of lives.
To those who invest now. Your gains would multiply exponentially and you wont have to wait long because the FDA will fast track this clinical trial following its approval (2021).
$0.75-$1.10 with FDA approval
$2-$2.30 during expedited clinical trial
$10+ /buyout w/successful trial
PMCB’s [Cell in a Box] technology is a DRUG SMUGGLER. Smuggling DEATH to CANCER. (MEGA SLEEPER 2021)
The Cell-in-a-Box technology, developed by Austrianova, is a means to protect, isolate, store and transport living cells.
It facilitates the safe implantation of cells, holding them isolated from the immune system (without this technology it would otherwise be seen as a foreign agent and killed..by the immune system)
“When the ifosfamide comes in contact with the encapsulated cells, those cells act as an artificial liver and activate the chemotherapy drug at the source of the cancer” -Pharmacyte CEO Kenneth Waggoner
Kenneth Waggoner
I have a GREAT feeling about this week.
Uncle Kenny is Bullish
PMCB’s [Cell in a Box] technology is BASICALLY a DRUG SMUGGLER. Smuggling DEATH to CANCER. (MEGA SLEEPER 2021)
The Cell-in-a-Box technology, developed by Austrianova, is a means to protect, isolate, store and transport living cells.
It facilitates the safe implantation of cells, holding them isolated from the immune system (without this technology it would otherwise be seen as a foreign agent and killed..by the immune system)
“When the ifosfamide comes in contact with the encapsulated cells, those cells act as an artificial liver and activate the chemotherapy drug at the source of the cancer” -Pharmacyte CEO Kenneth Waggoner
$0.75-$1.10 with FDA approval
$2-$2.30 during expedited clinical trial
$10+ /buyout w/successful trial
PMCB’s Cell in a Box technology and the treatment associated with it will change the way Cancers and Diabetes are treated and it will save millions maybe billions of lives. How can you possibly put a price on that?
Well you can and its HUGE >$10 a share HUGE.
Biotech stocks (like PMCB) with only one project naturally have a very low stock price because there is risk. Those who invest are investing in that one technology rather than the company as a whole.
To those who invest now. Your gains would multiply exponentially and you wont have to wait long because the FDA will fast track this clinical trial following its approval (2021).
RISK/REWARD Ive chosen risk with 16,400,000 shares. Why? Because of the price. Its too low. Way to low.. knowing that we could find out THIS year if PMCB’s novel technology will get its chance to change our world. Treating Cancers, diabetes and more ailments.
THATS insane, right? Its off the radar for many reasons. Ive talked about it before. None of those reasons are good.
When the FDA approves the clinical trial it will be on everyones radar. And the stock price will explode -before- it even gets started with the trials.
Given WHAT this treatment is capable of and the millions it will make for investors... Id say if your lucky enough to know about it now.. then invest.
Now is the time to invest because the reward is a million times greater then the risk.
Kenny “The Last Rough Rider” Waggoner
Just wait till next week ;)
Agreed. And cheers to the longs who have endured. No one deserves this win more than you all. GO PMCB
PMCB is an incredible investment. The same technology (cell in a box) can treat multiple cancers, diabetes and likely other ailments. And with over 16,000,000 shares I am more than excited to watch them succeed.
“Say it” -Kenneth L Waggoner’
“Say uncle” -Kenneth L Waggoner’
KENNIS LICINIUS WAGRICANUS
“Say uncle” -Kenneth L Waggoner
Sir Wagsalot is a knight in shining armor and we are the damsels
Uncle Kenny is like a father to us
Kenneth L. Waggoner is the most underrated CEO in the history of the world.
KW is the GOLDEN standard of a human being
Kenneth can do anything he sets his mind on.
Kenny boy making things happen
PMCB Here are a few comments ive posted on
https://finance.yahoo.com/quote/PMCB/community/
‘Has anyone ever seen a stock this low so close to a potential blockbuster FDA approval?
Ive theorized why in a previous post but i am still shocked.’
(PMCB’s under 2 cents)
‘The FDA’s list is rapidly being addressed and we should know if we have an FDA approval in 2021’
‘Half of the list has nothing to do with the clinical hold. PMCB confirmed they have begun two of the major tests required and the rest is mostly additions and clarification.
Do you think the FDA was capable of giving PMCB exactly what was required before they submitted their ind? This is a new product. There is no guideline for something like this.’
‘There have been two major updates. This is not a company sitting around. They are moving. Fast.’
‘With the influx of new investors on the market i think PMCB will go much higher than people think once the FDA approves the ind’
‘PMCBs share price should be much higher
FOUR reasons why PMCB is so low
1. COVID
-There was a noticeable drop as the virus became a reality.
2. HATERS Bashing
-Many people feel burned by pharmacyte. Their only project has been in the works for MANY years and investors have lost a lot. There is a belief that the stock has been pumped on multiple occasions with nothing to show for it. SO we have years of mostly negative comments online.
3. FDA Hold
-I believe this was the last straw for many longs who have held on for SO many years. They refused to wait any longer & a raging corona virus didnt help.
4. ‘One’ Project Risk
-If the FDA rejects the ind then thats it. This is pharmacyte’s only project. Investors will lose everything.
FOUR reasons why PMCB should be higher
1. ‘One’ Project Gain
-On the flip side if the FDA accepts the ind then PMCB’s stock will EXPLODE.
2. Blockbuster Treatment
-Cancer treatments are big money.
Cell in a Box could treat many forms of cancer, diabetes & potentially more afflictions.
3. Fast Track
-A high percentage of patients die from pancreatic cancer. There is a very good chance that the trials get expedited.
4. Upside
-The upside is worth the risk at this price. I have over 16 million shares and i have no regrets. The risk is real but i believe in this treatment. It could help so many people and i hope its successful.’
Thanks all and good luck
“I think its time to give KW a raise in salary he only made 316,667 per the filed report with the SEC for 2020 which is not much in todays world”
AGREED he deserves it. What a talented man. KW has sacrificed so much to make this a reality.
:D
Pasted from another PMCB forum:
(post & two reactions)
‘Has anyone ever seen a stock this low so close to a potential blockbuster FDA approval?
Ive theorized why in a previous post but i am still shocked.’
1. Half of the list has nothing to do with the clinical hold. PMCB confirmed they have begun two of the major tests required and the rest is mostly additions and clarification.
Do you think the FDA was capable of giving PMCB exactly what was required before they submitted their ind? This is a new product. There is no guideline for something like this.
2. There have been two major updates. This is not a company sitting around. They are moving. Fast.
Why would the FDA make a list if the ind was rejected. Zero sense. According to you and many other that believe this.. the FDA is trying to waste both their time and PMCB’s time.
And here it is. About to capitalize on its investment into austrianova
PMCBs a sleeping giant of a penny stock
With the influx of new investors on the market i think PMCB will go much higher than people think once the FDA approves the ind
Thanks
I hope so too and i understand what your saying.